- Home
- PCRX vs NEXN Comparison
PCRX vs NEXN Comparison
Compare PCRX & NEXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- NEXN
- Stock Information
- Founded
- PCRX 2006
- NEXN 2007
- Country
- PCRX United States
- NEXN Israel
- Employees
- PCRX N/A
- NEXN N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- NEXN Computer Software: Programming Data Processing
- Sector
- PCRX Health Care
- NEXN Technology
- Exchange
- PCRX Nasdaq
- NEXN Nasdaq
- Market Cap
- PCRX 604.7M
- NEXN 517.8M
- IPO Year
- PCRX 2011
- NEXN 2021
- Fundamental
- Price
- PCRX $16.52
- NEXN $7.48
- Analyst Decision
- PCRX Buy
- NEXN Strong Buy
- Analyst Count
- PCRX 10
- NEXN 5
- Target Price
- PCRX $26.60
- NEXN $9.30
- AVG Volume (30 Days)
- PCRX 545.3K
- NEXN 79.2K
- Earning Date
- PCRX 11-06-2024
- NEXN 11-15-2024
- Dividend Yield
- PCRX N/A
- NEXN N/A
- EPS Growth
- PCRX N/A
- NEXN N/A
- EPS
- PCRX N/A
- NEXN 0.09
- Revenue
- PCRX $694,957,000.00
- NEXN $349,109,000.00
- Revenue This Year
- PCRX $4.59
- NEXN $7.53
- Revenue Next Year
- PCRX N/A
- NEXN $7.94
- P/E Ratio
- PCRX N/A
- NEXN $36.48
- Revenue Growth
- PCRX 4.40
- NEXN 1.55
- 52 Week Low
- PCRX $11.16
- NEXN $3.37
- 52 Week High
- PCRX $35.95
- NEXN $8.69
- Technical
- Relative Strength Index (RSI)
- PCRX 44.28
- NEXN 41.17
- Support Level
- PCRX $16.11
- NEXN $7.96
- Resistance Level
- PCRX $18.34
- NEXN $7.71
- Average True Range (ATR)
- PCRX 0.83
- NEXN 0.25
- MACD
- PCRX -0.17
- NEXN -0.07
- Stochastic Oscillator
- PCRX 5.33
- NEXN 18.34
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.
About NEXN Nexxen International Ltd. American Depository Shares
Nexxen International Ltd empowers advertisers, agencies, publishers, and broadcasters to utilize video and connected TV. It is a demand-side platform (DSP), supply-side platform (SSP), ad server, and data management platform (DMP) and also delivers a flexible and unified technology stack with advanced and exclusive data at its core.